Grifols Therapeutics Llc

This study tests if a weekly shot under the skin (XEMBIFY) works as well as an IV infusion every three weeks (Gamunex-C) for people with CIDP, a chronic nerve condition. About 40 adults who are stable on IV treatment will first receive Gamunex-C for 19 weeks, then switch to XEMBI…

This study tests whether a medicine called XEMBIFY, given every two weeks alongside standard care, can reduce serious bacterial infections in adults with certain blood cancers (chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma) who also have low antibody lev…